Indications
Replacement treatment in acute attacks of angioedema in patients with congenital C1INH activity deficiency.
Composition
- Active substance
- recombinant human C1-inhibitor
- International name (INN)
- recombinant human C1 inhibitor
Official product information
The European public assessment report holds the summary of product characteristics and the package leaflet in every EU language.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Medicine
- Rhucin
- Active substance
- recombinant human C1-inhibitor
- ATC code
- B06C
- Therapeutic area
- Angioedema
- Marketing authorisation holder
- Pharming Group N.V.
- Status
- Refused